Fund Details
Overview
Investment portfolio
11rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
PreciseDx | Jun 2025Led | $11 MOther Equity | |
IOMED | Sep 2023Led | $12 MSeries A | |
Moving Analytics | Jul 2022Participated | $20 MSeries A | |
Suki | Dec 2021Participated | $55 MSeries C | |
Suki | Dec 2021Participated | $55 MSeries C | |
Doctor Anywhere | Aug 2021Participated | $66 MSeries C | |
Carevive Systems | Feb 2021Led | $18 MSeries C | |
Bright.md | May 2020Participated | $17 MSeries C | |
Orbita | May 2020Led | $9 MSeries A | |
DEARhealth | Jul 2019Participated | $7 MSeries A | |
LeQuest | May 2019Participated | $8 MOther Equity | |
PreciseDx | Jun 2025Led | $11 MOther Equity | |
IOMED | Sep 2023Led | $12 MSeries A | |
Moving Analytics | Jul 2022Participated | $20 MSeries A | |
Suki | Dec 2021Participated | $55 MSeries C | |
Suki | Dec 2021Participated | $55 MSeries C | |
Doctor Anywhere | Aug 2021Participated | $66 MSeries C | |
Carevive Systems | Feb 2021Led | $18 MSeries C | |
Bright.md | May 2020Participated | $17 MSeries C | |
Orbita | May 2020Led | $9 MSeries A | |
DEARhealth | Jul 2019Participated | $7 MSeries A | |
LeQuest | May 2019Participated | $8 MOther Equity |
11 Items
11
Items
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 2 | 2 |
| Series C+ | 1 | 4 |
| Other Equity | 1 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| May '19 | 1 |
| Jun '19 | 0 |
| Jul '19 | 1 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 2 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 1 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 1 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 2 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 1 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 1 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 1 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 9 |
| AI & Machine Learning | 4 |
| Networks, Cloud & Communication | 2 |
| Enterprise Software | 2 |
| Education & Workforce | 1 |
| Space & Frontier Tech | 1 |
| Social & Community Platforms | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 3 |
| $10M-$25M | 5 |
| $25M-$50M | 0 |
| $50M-$100M | 3 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 4 of 4 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 7 |
| Europe | 2 |
| Singapore | 1 |
| Japan | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Breyer Capital | 2 |
| Flare Capital Partners | 2 |
| Gaingels | 2 |
| InHealth Ventures | 2 |
| March Capital | 2 |
| Venrock | 2 |
| Adara Ventures | 1 |
| Asia Partners | 1 |
| B Capital Group | 1 |
| Cerner | 1 |
| Concord Health Partners | 1 |
| Cultivation Capital | 1 |
| Debiopharm | 1 |
| EASO Ventures | 1 |
| EDBI | 1 |
| Eventide Asset Management | 1 |
| Fondo Bolsa Social | 1 |
| GenHenn Capital | 1 |
| Health Innovations | 1 |
| HealthX Ventures | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 4 | 36% |
| Participating | 7 | 64% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 25% |
| Co-led | 3 | 75% |
Team
Lara Koole
Principle
Richard Wilmot
Head Of Group